Inhibition of Proteasome Function Leads to NF-κB-Independent IL-8 Expression in Human Hepatocytes

Hepatology

Volumn 38, Issue 5, 2003, Pages 1178-1187

  Joshi Barve, Swati ^a   Barve, Shirish S ^a   Butt, Waseem ^a   Klein, Jon ^a,b   McClain, Craig J ^a,b  

^a UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; PROTEASOME; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UBIQUITIN;

ALCOHOL LIVER CIRRHOSIS; APOPTOSIS; ARTICLE; CELL DIVISION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; FETUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; LIVER CELL; LIVER INJURY; NEUTROPHIL CHEMOTAXIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0142151770     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50470     Document Type: Article

References (44)

1. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998;8:397-403.
2. Donohue T. The ubiquitin-proteasome system and its role in ethanol-induced disorders. Addition Biology 2002;7:15-28.
3. Baraona E, Leo MA, Borowsky SA, Lieber CS. Pathogenesis of alcohol-induced accumulation of protein in the liver. J Clin Invest 1977;60:546-554.
4. Fataccioli V, Andraud E, Gentil M, French SW, Rouach H. Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. HEPATOLOGY 1999;29:14-20.
5. Takagi M, Yamauchi M, Toda G, Takada K, Hirakawa T, Ohkawa K. Serum ubiquitin levels in patients with alcoholic liver disease. Alcohol Clin Exp Res 1999;23:76S-80S.
6. Bardag-Gorce F, van Leeuwen FW, Nguyen V, French BA, Li J, Riley N, McPhaul LW, et al. The role of the ubiquitin-proteasome pathway in the formation of Mallory bodies. Exp Mol Pathol 2002;73:75-83.
7. French BA, van Leeuwen F, Riley NE, Yuan QX, Bardag-Gorce F, Gaal K, Lue YH, et al. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol 2001;71:241-246.
8. Perez MJ, Cederbaum AI. Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells. HEPATOLOGY 2003;37:1395-1404.
9. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002;7:23-27.
10. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002;72:847-855.
11. Jaeschke H, Mullen KD, Moradpour D. Comments. Inflammation in response to hepatocellular apoptosis. HEPATOLOGY 2002;35:964-965.
12. Hill DB, Marsano L, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. HEPATOLOGY 1993;18:576-580.
13. Hill DB, Schmidt J, Shedlofsky SI, Cohen DA, McClain CJ. In vitro tumor necrosis factor cytotoxicity in Hep G2 liver cells. HEPATOLOGY 1995;21:1114-1119.
14. Dooley DC, Simpson JF, Meryman HT. Isolation of large numbers of fully viable human neutrophils: a preparative technique using Percoll density gradient centrifugation. Exp Hematol 1982;10:591-599.
15. Nanjii AA, Su GL, Laposata M, French SW. Pathogenesis of alcoholic liver disease-recent advances. Alcohol Clin Exp Res 2002;26:731-736.
16. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-176.
17. Cederbaum AI, Wu D, Mari M, Bai J. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 2001;31:1539-1543.
18. Schuchmann M, Galle PR. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001;13:785-790.
19. Deaciuc IV, D'Souza NB, de Villiers WJ, Burikhanov R, Sarphie TG, Hill DB, McClain CJ. Inhibition of caspases in vivo protects the rat liver against alcohol-induced sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2001;25:935-943.
20. Deaciuc IV, Fortunato F, D'Souza NB, Hill H, McClain CJ. Chronic alcohol exposure of rats exacerbates apoptosis in hepatocytes and sinusoidal endothelial cells. Hepatol Res 2001;19:306-334.
21. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, Jones DA. Activation of caspase-3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998;160:3480-3486.
22. Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin- and Fas-antibody-mediated liver injury. HEPATOLOGY 1998;28:761-767.
23. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-49082.
24. Thornton AJ, Ham J, Kunkel SL. Kupffer cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. HEPATOLOGY 1991;14:1112-1122.
25. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. HEPATOLOGY 1993;18:41-46.
26. McClain CJ, Hill DB, Song Z, Dezciuc I, Barve S. Monocyte activation in alcoholic liver disease. Alcohol 2002;27:53-61.
27. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001;99:201-210.
28. Maher JJ, Scott MK, Saito JM, Burton MC. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. HEPATOLOGY 1997;25:624-630.
29. Zoli M, Tepper M, Lohez M, Arcangeli G, Ganne N, Christidis C, Trinchet J-C, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001;34:254-260.
30. Rogers HW, Callery MP, Deck B, Unanue ER. Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol 1996;156:679-684.
31. Schäfer T, Scheuer C, Roemer K, Menger MD, Vollmar B. Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. FASEB J 2003;17:660-667.
32. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998;177:1275-1281.
33. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 1993;90:10193-10197.
34. Fiedler MA, Wernke-Dollries K, Stark JM. Inhibition of TNF-alpha-induced NF-κB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am J Respir Cell Mol Biol 1998;19:259-268.
35. Elliott CL, Allport VC, Loudon JA, Wu GD, Bennett PR. Nuclear factor-κB is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod 2001;7:787-790.
36. Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D. Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→NIK→ IKK→NF-κB signal transduction pathway that induces transcription of interleukin-8. Infect Immun 2001;69:2270-2276.
37. Mahieux R, Lambert PF, Agbottah E, Halanski MA, Deng L, Kashanchi F, Brady JN. Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein. J Virol 2001;75:1736-1743.
38. Lakshminarayanan V, Drab-Weiss EA, Roebuck KA. H2O2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998;273:32670-32678.
39. Roebuck KA. Regulation of IL-8 gene expression. J Interferon Cytokine Res 1999;19:429-438.
40. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 1993;268:25568-25576.
41. Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D. Role of NF-κB in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000;165:3384-3392.
42. Jaspers I, Samet JM, Reed W. Arsenite exposure of cultured airway epithelial cells activates κB-dependent interleukin-8 gene expression in the absence of nuclear factor-κB nuclear translocation. J Biol Chem 1999;274:31025-31033.
43. Hipp MS, Urbich C, Mayer P, Wischhusen J, Weller M, Kracht M, Spyridopoulos I. Proteasome inhibition leads to NF-κB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Eur J Immunol 2002;32:2208-2217.
44. Wu HM, Wen HC, Lin WW. Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun Nterminal kinase activation. Am J Respir Cell Mol Biol. 2002;27:234-243.